EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Culprits of Medication-Induced Telogen Effluvium, Part 1

Donglin Zhang, Charlotte LaSenna, Bridget E Shields

Cutis · 2023

DOI: 10.12788/cutis.0910 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cutis, 2023. Verfasst von Donglin Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telogen effluvium (TE) is a common clinical consequence of medication-related alopecia. The inciting cause of TE may be difficult to identify due to delays in clinically apparent hair loss. Because medication-induced TE is a nonscarring alopecia that typically is reversible, appropriate management requires identification of the underlying triggering medication and cessation of it, if possible. In part 1 of this series, we review the existing literature on medication-induced TE with a focus on systemic retinoids, antifungal agents, and psychotropic medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataHumansAlopecia

Autor:innen und Institutionen

  • Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.

Zitieren

APA

Zhang, D., LaSenna, C., & Shields, B. E. (2023). Culprits of Medication-Induced Telogen Effluvium, Part 1. Cutis. https://doi.org/10.12788/cutis.0910

Vancouver

Zhang D, LaSenna C, Shields BE. Culprits of Medication-Induced Telogen Effluvium, Part 1. Cutis. 2023. doi:10.12788/cutis.0910

BibTeX
@article{Zhang2023,
  author = {Zhang, Donglin and LaSenna, Charlotte and Shields, Bridget E},
  title = {Culprits of Medication-Induced Telogen Effluvium, Part 1},
  journal = {Cutis},
  year = {2023},
  doi = {10.12788/cutis.0910}
}
Kostenlos starten →